Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Feb 11, 2023
Date Accepted: May 30, 2023

The final, peer-reviewed published version of this preprint can be found here:

Deep Learning–Assisted Gait Parameter Assessment for Neurodegenerative Diseases: Model Development and Validation

Jing Y, Qin P, Fan X, Qiang W, Zhu W, Sun W, Tian F, Wang D

Deep Learning–Assisted Gait Parameter Assessment for Neurodegenerative Diseases: Model Development and Validation

J Med Internet Res 2023;25:e46427

DOI: 10.2196/46427

PMID: 37405831

PMCID: 10357315

Deep Learning Assisted Gait Parameter Assessment of Neurodegenerative Diseases: Model Development and Validation

  • Yu Jing; 
  • Peinuan Qin; 
  • Xiangmin Fan; 
  • Wei Qiang; 
  • Wencheng Zhu; 
  • Wei Sun; 
  • Feng Tian; 
  • Dakuo Wang

ABSTRACT

Background:

Neurodegenerative diseases (NDD) are common among older adults worldwide. Early diagnosis of NDD is a difficult but rewarding task. Gait status has been shown to be an indicator of changes in the early stages of NDD and can play a significant role in diagnosis, treatment, and rehabilitation. In the past, assessments of gait either relied on complex but imprecise scales by trained doctors or required patients to wear additional equipment that made them uncomfortable. Advances in artificial intelligence may change this completely and provide a new approach to gait evaluation.

Objective:

This study sought to use cutting-edge machine learning outcomes to (1) provide patients with a non-invasive gait assessment in a completely non-contact manner, (2) provide healthcare professionals with accurate gait assessment results covering all common gait-related parameters to assist them in diagnosis and rehabilitation planning.

Methods:

The data collection included motion data from 41 different subjects aged 25-85 years, with an average age of 57.51 years, captured in motion sequences with the Kinect (a 3D camera with a sampling frequency of 30HZ). To identify the type of gait in each frame of the walk, we used Support Vector Machine (SVM) and Bi-directional Long short-term memory (Bi-LSTM) classifiers that were trained by spatio-temporal features extracted from the raw data. Then, the gait semantics could be obtained from the frame labels. Finally, all gait parameters can be calculated according to gait semantics. To ensure the best generalization performance of the model, classifiers were trained under a 10-fold cross-validation strategy. Furthermore, the proposed algorithm is also compared with the previous best heuristic method. The qualitative and quantitative feedback from the medical staff and patients in the actual medical scenarios are also widely collected for usability analysis.

Results:

Evaluations were made for 3 aspects. For the two classifiers classification result, the Bi-LSTM achieved an average precision, recall, and F1-score of 90.54%, 90.41%, and 90.38% separately, while these metrics of SVM are 86.99%, 86.62%, and 86.67%. Moreover, the Bi-LSTM-based method attained an accuracy of 93.2% when taking the gait segmentation evaluation (tolerance is set to 2) while that of the SVM-based method was only 77.5%. For the final gait parameter calculation result, the average error rate of the heuristic, SVM and Bi-LSTM is 20.91%, 5.85%, and 3.17% respectively, and the average standard deviation error of them are 24.69%, 5.45%, and 2.75%.

Conclusions:

This study proves that the Bi-LSTM-based approach can provide strong support for the accurate assessment of gait parameters to help medical staff to make early diagnoses and reasonable rehabilitation plans for patients with NDD.


 Citation

Please cite as:

Jing Y, Qin P, Fan X, Qiang W, Zhu W, Sun W, Tian F, Wang D

Deep Learning–Assisted Gait Parameter Assessment for Neurodegenerative Diseases: Model Development and Validation

J Med Internet Res 2023;25:e46427

DOI: 10.2196/46427

PMID: 37405831

PMCID: 10357315

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.